LLY compared with RANI: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

RANIRani Therapeutics Holdings, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

RANIRani Therapeutics Holdings, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Shared 0

No shared counterparties.

Only RANI 6

—Celltrionunlistedsupplier

—Chugai Pharmaceuticalunlistedsupplier

—ProGenunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

ICL

unlistedsupplier

2 more · RANI chain ›

LLYELI Lilly & Co

1,360.90▼−0.28%· post 1,356.71· delayed

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

RANIRani Therapeutics Holdings, Inc.

0.52▼−0.10%· post 0.55· delayed

After hoursNov 6 '26delayed

Mkt cap$72.0MRevenue$2MQ2 FY26Revenue—

Compare

After hoursNov 6 '26delayed

LLYELI Lilly & Co

RANIRani Therapeutics Holdings, Inc.

1,360.90▼−0.28%post 1,356.71delayed

Price

0.52▼−0.10%post 0.55delayed

$1.2T

Mkt cap

$72.0M

Q3 FY26$24.4B

Revenue

$2MQ2 FY26

FY25$65.2B

Revenue

—

LLY1,360.90▼−0.28%vsRANI0.52▼−0.10%After hoursNov 6 '26delayed